Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Cigna (CI) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareHealthcare PlansCI

Latest price · Nov 20, 2026 $278.00 +1.8% on the day · +5.5% over 12 months 52-week range $255.18 – $315.88
Get CI alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling4last 12 months
Reported sales$66.8M19 of 20 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Past insider buys here: 1 of 1 beat the S&P 500 over the next 90 days (small sample). See each one ↓

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 11, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Everett Neville, See Remarks sold 617 shares at $284.05 ($175K).

Trade date
Sep 3, 2026
Disclosed to the SEC
Sep 8, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All CI insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

CI insider transactions (Form 4)

Open-market purchases and sales. 47 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Sep 8SEC Everett NevilleSee Remarks Sell Plan 6175,053 held (−11%) $284.05 $175K -2.1% —
Aug 20SEC Nicole S. JonesSee Remarks Sell Plan 2,67725,880 held (−9%) $279.61 $749K -0.6% —
Aug 6SEC Nicole S. JonesSee Remarks Sell Plan 19,43627,256 held (−42%) $276.27 $5.4M +0.6% —
Jun 16SEC Jamie G. KatesChief Accounting Officer Sell 8992,368 held (−28%) $298.61 $268K -6.9% —
May 14SEC David CordaniCEO, Chair Sell Plan 41,099163,082 held (−20%) $290.00 $11.9M -4.1% —
May 14SEC David CordaniCEO, Chair Sell Plan 38,48788,545 held (−30%) $294.98 $11.4M -5.8% —
May 14SEC David CordaniCEO, Chair Sell Plan 34,64153,904 held (−39%) $295.98 $10.3M -6.1% —
May 14SEC David CordaniCEO, Chair Sell Plan 15,31936,568 held (−30%) $298.24 $4.6M -6.8% —
May 14SEC David CordaniCEO, Chair Sell Plan 14,292218,020 held (−6%) $287.96 $4.1M -3.5% —
May 14SEC David CordaniCEO, Chair Sell Plan 13,839204,181 held (−6%) $288.85 $4.0M -3.8% —
May 14SEC David CordaniCEO, Chair Sell Plan 13,732149,350 held (−8%) $291.01 $4.0M -4.5% —
May 14SEC David CordaniCEO, Chair Sell Plan 12,315137,035 held (−8%) $291.95 $3.6M -4.8% —
May 14SEC David CordaniCEO, Chair Sell Plan 7,861129,174 held (−6%) $292.88 $2.3M -5.1% —
May 14SEC David CordaniCEO, Chair Sell Plan 3,903232,312 held (−2%) $286.83 $1.1M -3.1% —
May 14SEC David CordaniCEO, Chair Sell Plan 2,23134,337 held (−6%) $298.53 $666K -6.9% —
May 14SEC David CordaniCEO, Chair Sell Plan 2,142127,032 held (−2%) $293.92 $630K -5.4% —
May 14SEC David CordaniCEO, Chair Sell Plan 2,01751,887 held (−4%) $296.84 $599K -6.3% —
Mar 3SEC Nicole S. JonesSee Remarks Sell Plan 2,30732,647 held (−7%) $288.91 $667K -3.8% —
Mar 3SEC Everett NevilleSee Remarks Sell Plan 1,7195,670 held (−23%) $288.91 $497K -3.8% —
Nov 3SEC David CordaniCEO, ChairFirst buy Buy 4,134157,935 held (+3%) $241.88 $1000K +14.9% —
Oct 7SEC Brian C. EvankoSee Remarks Sell Plan 5,36851,182 held (−9%) $300.00 $1.6M -7.3% —
Historical context

Similar past setups: not applicable. CI has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with CI in the Research Lab

Pre-set to CI's latest insider buy of $10K or more (Nov 3, 2025: David Cordani, $1000K). Tap to change anything.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

CI closeInsider buyInsider sale
240260280300320DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-05EEarnings release filed 2026-04-30EEarnings release filed 2026-07-30EEarnings release filed 2026-11-05Sold $175,259 on 2026-09-03 · Everett NevilleSold $268,452 on 2026-06-12 · Jamie G. KatesSold $748,516 on 2026-08-18 · Nicole S. JonesSold $1,163,152 on 2026-03-02 · Everett Neville, Nicole S. JonesSold $5,369,584 on 2026-08-04 · Nicole S. JonesSold $59,114,186 on 2026-05-12 · David Cordani
Bought, 12 months$0
Sold, 12 months$66.8M
Insiders buying0
Insiders selling4

Cigna insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $66.8M of CI stock on the open market; P/E 13.2 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

CI insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $1000K bought (1 trades)$1000KQ4 2025: $1.6M sold (1 trades)Q4 2025Q1 2026: $1.2M sold (2 trades)Q1 2026Q2 2026: $59.4M sold (14 trades)Q2 2026Q3 2026: $6.3M sold (3 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$6.3M3
Q2 2026—0$59.4M14
Q1 2026—0$1.2M2
Q4 2025$1000K1$1.6M1

Valuation, profit and volume

P/E (trailing)13.2Sector median 25.0
Market value$78.99BHealthcare Plans
Profit margin2.1%Revenue growth +5.6%
Volume vs. 50-day1.1×Last 5 sessions
Insiders' paper profit+$149KOn all tracked purchases +14.9%

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Cigna insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $66.8M. Among insiders with enough purchase history to measure, Eric J. Foss (Director) has the highest Insider Score at 66. 19 of 20 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

CI earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 5, 2026 -0.4% None -3.9%S&P -4.1% pending
Jul 30, 2026 -2.3% None -5.9%S&P +2.4% -0.1%
Apr 30, 2026 +7.2% None -3.2%S&P +1.3% -1.9%
Feb 5, 2026 +0.2% None +7.5%S&P +0.6% -6.5%
Oct 30, 2025 -1.0% Sold $1.6M -18.3%S&P -0.8% +13.4%
Jul 31, 2025 -1.5% None -12.0%S&P -2.0% +14.7%
May 2, 2025 +1.7% None -0.6%S&P +0.9% -6.4%
Jan 30, 2025 +6.4% None -3.0%S&P +0.0% +5.0%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

CI short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 38% of volume sold short2026-08-27: 37% of volume sold short2026-08-28: 55% of volume sold short2026-08-31: 33% of volume sold short2026-09-01: 39% of volume sold short2026-09-02: 50% of volume sold short2026-09-03: 58% of volume sold short2026-09-04: 65% of volume sold short2026-09-08: 65% of volume sold short2026-09-09: 51% of volume sold short2026-09-10: 63% of volume sold short2026-09-11: 53% of volume sold short2026-09-14: 45% of volume sold short2026-09-15: 58% of volume sold short2026-09-16: 50% of volume sold short2026-09-17: 66% of volume sold short2026-09-18: 53% of volume sold short2026-09-21: 54% of volume sold short2026-09-22: 41% of volume sold short2026-09-23: 48% of volume sold short2026-09-24: 34% of volume sold short2026-09-25: 37% of volume sold short2026-09-28: 49% of volume sold short2026-09-29: 48% of volume sold short2026-09-30: 62% of volume sold short2026-10-01: 53% of volume sold short2026-10-02: 47% of volume sold short2026-10-05: 48% of volume sold short2026-10-06: 34% of volume sold short2026-10-07: 42% of volume sold short2026-10-08: 42% of volume sold short2026-10-09: 54% of volume sold short2026-10-12: 62% of volume sold short2026-10-13: 68% of volume sold short2026-10-14: 40% of volume sold short2026-10-15: 37% of volume sold short2026-10-16: 58% of volume sold short2026-10-19: 47% of volume sold short2026-10-20: 48% of volume sold short2026-10-21: 50% of volume sold short2026-10-22: 56% of volume sold short2026-10-23: 66% of volume sold short2026-10-26: 44% of volume sold short2026-10-27: 40% of volume sold short2026-10-28: 40% of volume sold short2026-10-29: 32% of volume sold short2026-10-30: 31% of volume sold short2026-11-02: 29% of volume sold short2026-11-03: 26% of volume sold short2026-11-04: 50% of volume sold short2026-11-05: 52% of volume sold short2026-11-06: 36% of volume sold short2026-11-09: 61% of volume sold short2026-11-10: 29% of volume sold short2026-11-11: 55% of volume sold short2026-11-12: 52% of volume sold short2026-11-13: 58% of volume sold short2026-11-16: 53% of volume sold short2026-11-17: 50% of volume sold short2026-11-18: 61% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 61%20-day average: 47%Prior 2 months: 50%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded CI

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +7.3%

What happened after CI insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Nov 3, 2025David CordaniCEO, Chair$1000K -0.2%+0.1% vs S&P+4.5%+4.4% vs S&P+5.6%+3.5% vs S&P

Insiders at Cigna

InsiderBoughtSoldLast filingPast buys beat S&PScore
David CordaniCEO, Chair $1000K $59.1M May 14, 2026 1 of 1 —
Nicole S. JonesSee Remarks — $6.8M Aug 20, 2026 — —
Brian C. EvankoSee Remarks — $1.6M Sep 3, 2026 — —
Everett NevilleSee Remarks — $672K Sep 8, 2026 — —
Jamie G. KatesChief Accounting Officer — $268K Jun 16, 2026 — —
Durga Prasad KokaEvp, Global Cio — — Jun 3, 2026 — —
Eric C. WisemanDirector — — Apr 24, 2026 — —
Philip OzuahDirector — — Apr 24, 2026 — —
Michael J. HenniganDirector — — Apr 24, 2026 — —
Kimberly A. RossDirector — — Apr 24, 2026 — —
George KurianDirector — — Apr 24, 2026 — —
Kathleen M. MazzarellaDirector — — Apr 24, 2026 — —
Donna F. ZarconeDirector — — Apr 24, 2026 0 of 1 —
Neesha HathiDirector — — Apr 24, 2026 — —
Mark B. McClellanDirector — — Apr 24, 2026 — —
Eric J. FossDirector — — Apr 24, 2026 0 of 1 66
Ann M. DennisonCFO — — Mar 3, 2026 — —

Board links: companies that share insiders with CI

Directors and executives who filed Form 4s for CI and another company in the last 12 months.

See the map →
  • CDWCDW Donna F. Zarcone Director here · Director at CDW · latest filing Apr 24, 2026
  • KKRKKR Kimberly A. Ross Director here · Director at KKR · latest filing Apr 24, 2026
  • KYNKayne Anderson Energy Infrastructure Fund Michael J. Hennigan Director here · Director at KYN · latest filing Jun 24, 2026
  • MPCMarathon Petroleum Michael J. Hennigan Director here · Chair at MPC · latest filing Apr 24, 2026
  • NOCNorthrop Grumman Kimberly A. Ross Director here · Director at NOC · latest filing May 21, 2026
  • NTAPNetApp George Kurian Director here · CEO at NTAP · latest filing Nov 17, 2026
  • PRMBPrimo Brands Eric J. Foss Director here · CEO, Chair at PRMB · latest filing Aug 12, 2026
  • SCHWCharles Schwab Neesha Hathi Director here · Md, Head Wealth Adv, Bnk, Tst at SCHW · latest filing Nov 3, 2026
  • TNETTrinet Group Brian C. Evanko See Remarks here · Director at TNET · latest filing Sep 3, 2026
  • WMWaste Management Kathleen M. Mazzarella Director here · Director at WM · latest filing May 18, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

CI stock: common questions

Are Cigna insiders buying CI stock?

No. No Cigna insider reported an open-market purchase of CI in the past 12 months. The latest was CEO, Chair David Cordani bought $1000K of CI at $241.88 — first open-market purchase in our records.

Are Cigna insiders selling CI stock?

4 insiders reported sales worth $66.8M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CI's P/E ratio?

CI trades at about 13.2 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is CI's 52-week range?

Over the past year CI has traded between $255.18 and $315.88. It last closed at $278.00 on Nov 20, 2026.